Components of the anti-Mullerian hormone signaling pathway in gonads

被引:87
作者
di Clemente, N [1 ]
Josso, N [1 ]
Gouédard, L [1 ]
Belville, C [1 ]
机构
[1] INSERM, Unite 493, F-92140 Clamart, France
关键词
anti-Mullerian hormone; Mullerian inhibiting substance; anti-Mullerian hormone type II receptor; activin receptor-like kinase; signaling pathway; gonads;
D O I
10.1016/j.mce.2003.09.005
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Anti-Mullerian hormone (AMH) is a member of the Transforming Growth Factor-beta (TGF-beta) family implicated in the regression of Mullerian ducts in male fetuses and in the development and function of gonads of both sexes. Members of the TGF-beta family signal through two types of serine/threonine kinase receptors called type I and type II, and two types of Smad proteins, receptor-regulated Smad (R-Smad) and common Smad, Smad4. Components of the AMH signaling pathway have been identified in gonads and gonadal cell lines. The AMH type II receptor is highly specific. In contrast, the identity of the AMH type I receptor is not clear; three type I receptors of Bone Morphogenetic Proteins (BMPs), Alk2, Alk3 and Alk6 may transduce AMH signals, but none of them has all the characteristics of an AMH type I receptor. AMH activates BMP-specific R-Smads and reporter genes. (C) 2003 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:9 / 14
页数:6
相关论文
共 30 条
[1]  
Allard S, 2000, DEVELOPMENT, V127, P3349
[2]   ANTI-MULLERIAN HORMONE AND ANTI-MULLERIAN HORMONE TYPE-II RECEPTOR MESSENGER-RIBONUCLEIC-ACID EXPRESSION DURING POSTNATAL TESTIS DEVELOPMENT AND IN THE ADULT TESTIS OF THE RAT [J].
BAARENDS, WM ;
HOOGERBRUGGE, JW ;
POST, M ;
VISSER, JA ;
DEROOIJ, DG ;
PARVINEN, M ;
THEMMEN, APN ;
GROOTEGOED, JA .
ENDOCRINOLOGY, 1995, 136 (12) :5614-5622
[3]  
BAARENDS WM, 1994, DEVELOPMENT, V120, P189
[4]   ANTI-MULLERIAN HORMONE AND ANTI-MULLERIAN HORMONE TYPE-II RECEPTOR MESSENGER-RIBONUCLEIC-ACID EXPRESSION IN RAT OVARIES DURING POSTNATAL-DEVELOPMENT, THE ESTROUS-CYCLE, AND GONADOTROPIN-INDUCED FOLLICLE GROWTH [J].
BAARENDS, WM ;
UILENBROEK, JTJ ;
KRAMER, P ;
HOOGERBRUGGE, JW ;
VANLEEUWEN, ECM ;
THEMMEN, APN ;
GROOTEGOED, JA .
ENDOCRINOLOGY, 1995, 136 (11) :4951-4962
[5]   MULLERIAN-INHIBITING SUBSTANCE FUNCTION DURING MAMMALIAN SEXUAL DEVELOPMENT [J].
BEHRINGER, RR ;
FINEGOLD, MJ ;
CATE, RL .
CELL, 1994, 79 (03) :415-425
[6]   TYPE-I RECEPTORS SPECIFY GROWTH-INHIBITORY AND TRANSCRIPTIONAL RESPONSES TO TRANSFORMING GROWTH-FACTOR-BETA AND ACTIVIN [J].
CARCAMO, J ;
WEIS, FMB ;
VENTURA, F ;
WIESER, R ;
WRANA, JL ;
ATTISANO, L ;
MASSAGUE, J .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (06) :3810-3821
[8]   Grading and staging of bladder carcinoma in transurethral resection specimens - Correlation with 105 matched cystectomy specimens [J].
Cheng, L ;
Neumann, RM ;
Weaver, AL ;
Cheville, JC ;
Leibovich, BC ;
Ramnani, DM ;
Scherer, BG ;
Nehra, A ;
Zincke, H ;
Bostwick, DG .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2000, 113 (02) :275-279
[9]   Mullerian inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces Smad6 expression [J].
Clarke, TR ;
Hoshiya, Y ;
Yi, SE ;
Liu, XH ;
Lyons, KM ;
Donahoe, PK .
MOLECULAR ENDOCRINOLOGY, 2001, 15 (06) :946-959
[10]   DISTINCT SPATIAL AND TEMPORAL EXPRESSION PATTERNS OF 2 TYPE-I RECEPTORS FOR BONE MORPHOGENETIC PROTEINS DURING MOUSE EMBRYOGENESIS [J].
DEWULF, N ;
VERSCHUEREN, K ;
LONNOY, O ;
MOREN, A ;
GRIMSBY, S ;
VANDESPIEGLE, K ;
MIYAZONO, K ;
HUYLEBROECK, D ;
TENDIJKE, P .
ENDOCRINOLOGY, 1995, 136 (06) :2652-2663